Nanotechnology basics, news, and general information

Welcome to the world's most in-depth, online resource for the global economy's fastest growing information and investment sector.

We offer consulting, technology monitoring, and in-depth analysis, as well as up-to-the-minute news briefs and breaking developments in the nanosciences. The world's leading nanotech experts routinely contribute to Nanotechnology Now, which has become the daily 'must read' site for stakeholders: inventors, investors, policy makers and opinion shapers.

We are your resource for:

• Reporting on disruptive technologies (such as Artificial Intelligence, NEMS, MEMS, Nanoscale Materials, Molecular Manufacturing, Quantum Computing, Nanomedicine, Nanoelectronics, Nanotubes, Self Assembly, and Molecular Biology)
• New developments in nanotech inventions, patents, and patent applications
• White papers, interviews with industry leaders, and in-depth analysis
• Full-service consulting
• Investment opportunities in nanotech
• Opportunities for venture capitalists
• Late breaking news and industry updates

From Nanodemographics: Crisis and Opportunity

If most adults in the US don't understand what nanotechnology is, how will they greet the new products and processes being developed? And what can nano companies do to protect their investments? Read the Whole Article

— Laura Wright, Vice President, CameronWeeks Public Relations

From Patenting a Novel Industrial Method for Hydroxyapatite Nanoparticles.

Co-author Dr. Jose Carlos Lopes, Chairman.
www.fluidinova.pt/
Novelty and nonobviousness are two legal requirements to be met for an innovation to be patentable. These requirements are required to ensure that not just any innovation is patentable. Nanosized Hydroxyapatite is in great demand due to its medical use. It is an area where possibilities of novel methods are not exhausted yet. An example of these novel possibilities being given legal effect is a patent granted for a novel method of producing Hydroxyapatite nanoparticles. The invention tries to match natural Hydroxyapatite. This is a significant development for biopharma which is seeking ways to more effectively incorporate Hydroxyapatite into a wide range of biomedical uses. Read the Whole Article

— Magda Carvalho, Patent Agent (PhD, JD), Patent Law at M. Carvalho

From Nanosilver on the EPA Agenda

This column is by Philip Stiff, a member of the Project on Emerging Nanotechnologies team and a current student at the Georgetown Public Policy Institute:

On Nov. 19 EPA opened up a docket for comment on the May 1 petition filed by a coalition of 14 consumer advocacy groups that calls for regulation of products containing nanosilver. The petition requests that EPA ban the sale of products that contain nanosilver until the agency makes a regulatory determination that nanosilver is a new pesticidal substance, requiring toxicity and risk screening. Research summarized in the Project on Emerging Nanotechnologies document Silver Nanotechnologies and the Environment: Old Problems or New Challenges? shows that many nanosilver products release silver into public water treatment systems. This, in turn, presents toxicity risks to the aquatic environment. Consumer value of products containing nanosilver is great, especially in the medical field, which is all the more reason to move quickly to ensure risks are managed. Read the Whole Article

— David Rejeski, Director, Project on Emerging Nanotechnologies

From The Future of Healthcare

MEMS and nanotechnology are revolutionizing medicine; here's a peek at our future. Read the Whole Article

— Marlene Bourne, President & Principal Analyst, Bourne Research

From What the US can learn from the UK

A new report from the British goverment's Royal Commission on Environmental Pollution says "new governance arrangements are necessary" to deal with the profound implications of advanced nanotechnology, and warns that this "will take time, possibly decades, to develop and implement." It's gratifying to see these issues taken seriously (finally!) and we hope the US will follow the lead of their UK counterparts. Read the Whole Article

— Mike Treder, Center for Responsible Nanotechnology